Final answer:
The nurse should expect the provider to prescribe a measurement of Fibrin degradation products (FDP) in the case of a suspected placental abruption at 24 weeks of gestation to diagnose and monitor the severity of the condition.
Step-by-step explanation:
A nurse is caring for a client who is at 24 weeks of gestation and has a suspected placental abruption. One of the laboratory tests that the medical provider is likely to prescribe in this situation is the measurement of Fibrin degradation products (FDP). Since placental abruption can lead to disseminated intravascular coagulation (DIC), FDPs, which are produced when blood clots are broken down, can be elevated. These tests are pertinent to diagnosing and monitoring the severity of placental abruption. It is important to act quickly, as placental abruption can compromise the oxygen and nutrient delivery to the fetus and pose serious risks to both the pregnant person and the fetus.